申请人:IRM LLC
公开号:US20040235841A1
公开(公告)日:2004-11-25
The invention provides a novel class of cyclic compounds, pharmaceutical compositions comprising such cyclic compounds and methods of using such compounds to treat or prevent diseases and disorders associated with cyclin-dependent kinases (CDKs) activity, particularly diseases associated with the activity of CDK2 and CDK5.
该发明提供了一种新型环状化合物类,包括这种环状化合物的药物组合物和使用这些化合物治疗或预防与细胞周期依赖性激酶(CDKs)活性相关的疾病和障碍的方法,特别是与CDK2和CDK5活性相关的疾病。